| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (methicillin-resistant) |
2 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox)  |
189 |
| Staphylococci (methicillin-resistant) |
2 |
4 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
189 |
| Staphylococci (methicillin-resistant) |
4 |
16 |
0.12 － 32 |
Levofloxacin (Levaquin, Quixin) |
443 |
| Staphylococci (methicillin-resistant) |
>16 |
>16 |
0.5 － >16 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
189 |
| Staphylococci (methicillin-susceptible) |
0.03 |
0.25 |
0.008 － 0.25 |
Sitafloxacin |
443 |
| Staphylococci (methicillin-susceptible) |
0.06 |
0.25 |
0.015 － 0.5 |
DK-507k |
443 |
| Staphylococci (methicillin-susceptible) |
0.06 |
1 |
0.015 － 4 |
Garenoxacin (T-3811, BMS-284756) |
443 |
| Staphylococci (methicillin-susceptible) |
0.12 |
0.25 |
0.12 － 0.25 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
189 |
| Staphylococci (methicillin-susceptible) |
0.12 |
1 |
0.03 － 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
443 |
| Staphylococci (methicillin-susceptible) |
0.25 |
0.25 |
0.06 － 0.25 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
443 |
| Staphylococci (methicillin-susceptible) |
0.25 |
2 |
0.06 － 4 |
Gatifloxacin (Tequin) |
443 |
| Staphylococci (methicillin-susceptible) |
0.25 |
4 |
0.12 － 8 |
Levofloxacin (Levaquin, Quixin) |
443 |
| Staphylococci (methicillin-susceptible) |
0.25 |
8 |
0.06 － 64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
443 |
| Staphylococci (methicillin-susceptible) |
0.5 |
0.5 |
0.25 － 1 |
RWJ-416457 |
189 |
| Staphylococci (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
189 |
| Staphylococci (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
189 |
| Staphylococci (msr) |
0.03 |
0.06 |
≤0.015 － 0.06 |
Cethromycin (ABT-773) |
1111 |
| Staphylococci (msr) |
0.06 |
0.12 |
≤0.015 － 0.25 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
1111 |
| Staphylococci (msr) |
>128 |
>128 |
1 － >128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1111 |
| Staphylococci (Quinupristin/Dalfopristin-resistant) |
0.5 |
1 |
0.25 － 1 |
Daptomycin (Cubicin) |
483 |
| Staphylococci (Quinupristin/Dalfopristin-resistant) |
- |
- |
0.03 － 0.06 |
Dalbavancin |
1112 |
| Staphylococci (teicoplanin-resistant + coagulase-negative) |
0.25 |
0.5 |
≤0.12 － 0.5 |
Daptomycin (Cubicin) |
483 |
| Staphylococci (teicoplanin-resistant + coagulase-negative) |
0.25 |
0.5 |
≤0.25 － 1 |
Quinupristin/Dalfopristin (Synercid) |
483 |
| Staphylococci (teicoplanin-resistant + coagulase-negative) |
1 |
1 |
0.5 － 1 |
Linezolid (PNU-100766, U-100766, Zyvox) |
483 |
| Staphylococci (teicoplanin-resistant + coagulase-negative) |
2 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
483 |
| Staphylococci (teicoplanin-resistant + coagulase-negative) |
>4 |
>4 |
0.25 － >4 |
Levofloxacin (Levaquin, Quixin) |
483 |
| Staphylococci (teicoplanin-resistant + coagulase-negative) |
4 |
4 |
≤4 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
483 |
| Staphylococci (teicoplanin-resistant + coagulase-negative) |
>4 |
>16 |
≤2 － >16 |
Chloramphenicol (Chloromycetin) |
483 |